U.S. Markets open in 2 hrs 41 mins

The Key Challenges Teva Pharmaceutical Is Facing

Sarah Collins
The Key Challenges Teva Pharmaceutical Is Facing

Can Teva Pharmaceutical's Restructuring Plan Help It Recuperate? In December 2017, Teva Pharmaceutical Industries (TEVA) announced a restructuring plan to recuperate sales. Its stock has had a bull run since the announcement, rising 44.5% since the company’s weak earnings results for fiscal 3Q17 on November 2, 2017.